Telangiectasia, Hereditary Hemorrhagic

"Telangiectasia, Hereditary Hemorrhagic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

An autosomal dominant vascular anomaly characterized by telangiectases of the skin and mucous membranes and by recurrent gastrointestinal bleeding. This disorder is caused by mutations of a gene (on chromosome 9q3) which encodes endoglin, a membrane glycoprotein that binds TRANSFORMING GROWTH FACTOR BETA.

Descriptor ID	D013683
MeSH Number(s)	C14.907.454.900 C14.907.823.780 C15.378.463.515.900 C16.131.240.850.968
Concept/Terms	Telangiectasia, Hereditary Hemorrhagic Telangiectasia, Hereditary Hemorrhagic Hemorrhagic Telangiectasia, Hereditary Rendu-Osler-Weber Rendu Osler Weber Telangiectasia, Hereditary Hemorrhagic, of Rendu, Osler, and Weber Telangiectasia, Hereditary Hemorrhagic, Type 1 Osler-Rendu Disease Osler Rendu Disease Osler-Rendu-Weber Disease Osler Rendu Weber Disease Hereditary Hemorrhagic Telangiectasia Osler's Disease Disease, Osler's Osler Disease Osler-Weber-Rendu Syndrome Osler Weber Rendu Syndrome Weber-Osler Weber Osler

Below are MeSH descriptors whose meaning is more general than "Telangiectasia, Hereditary Hemorrhagic".

Diseases [C]
Cardiovascular Diseases [C14]
Vascular Diseases [C14.907]
Hemostatic Disorders [C14.907.454]
Telangiectasia, Hereditary Hemorrhagic [C14.907.454.900]
Telangiectasis [C14.907.823]
Telangiectasia, Hereditary Hemorrhagic [C14.907.823.780]
Hemic and Lymphatic Diseases [C15]
Hematologic Diseases [C15.378]
Hemorrhagic Disorders [C15.378.463]
Hemostatic Disorders [C15.378.463.515]
Telangiectasia, Hereditary Hemorrhagic [C15.378.463.515.900]
Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16]
Congenital Abnormalities [C16.131]
Cardiovascular Abnormalities [C16.131.240]
Vascular Malformations [C16.131.240.850]
Telangiectasia, Hereditary Hemorrhagic [C16.131.240.850.968]

Below are MeSH descriptors whose meaning is more specific than "Telangiectasia, Hereditary Hemorrhagic".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Telangiectasia, Hereditary Hemorrhagic" by people in this website by year, and whether "Telangiectasia, Hereditary Hemorrhagic" was a major or minor topic of these publications.

Bar chart showing 19 publications over 13 distinct years, with a maximum of 3 publications in 2024

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1996	1	0	1
1997	1	0	1
2002	0	1	1
2005	2	0	2
2010	1	0	1
2011	2	0	2
2012	2	0	2
2015	2	0	2
2018	1	0	1
2019	1	0	1
2021	1	0	1
2023	1	0	1
2024	3	0	3

Below are the most recent publications written about "Telangiectasia, Hereditary Hemorrhagic" by people in Profiles.

Beslow LA, White AJ, Krings T, Hammill AM, Lang SS, Baba A, Clancy MS, Olitsky SE, Hetts SW. Current Practice: Rationale for Screening Children with Hereditary Hemorrhagic Telangiectasia for Brain Vascular Malformations. AJNR Am J Neuroradiol. 2024 Sep 09; 45(9):1177-1184.

View in: PubMed
Beslow LA, Vossough A, Kim H, Nelson J, Lawton MT, Pollak J, Lin DDM, Ratjen F, Hammill AM, Hetts SW, Gossage JR, Whitehead KJ, Faughnan ME, Krings T. Brain AVM compactness score in children with hereditary hemorrhagic telangiectasia. Childs Nerv Syst. 2024 Jul; 40(7):2101-2108.

View in: PubMed
Beslow LA, Krings T, Kim H, Hetts SW, Lawton MT, Ratjen F, Whitehead KJ, Gossage JR, McCulloch CE, Clancy M, Bagheri N, Faughnan ME. De Novo Brain Vascular Malformations in Hereditary Hemorrhagic Telangiectasia. Pediatr Neurol. 2024 Jun; 155:120-125.

View in: PubMed
Cheng HC, Faughnan ME, terBrugge KG, Liu HM, Krings T. Prevalence and Characteristics of Intracranial Aneurysms in Hereditary Hemorrhagic Telangiectasia. AJNR Am J Neuroradiol. 2023 12 11; 44(12):1367-1372.

View in: PubMed
Thompson KP, Nelson J, Kim H, Weinsheimer SM, Marchuk DA, Lawton MT, Krings T, Faughnan ME. Utility of modified Rankin Scale for brain vascular malformations in hereditary hemorrhagic telangiectasia. Orphanet J Rare Dis. 2021 09 19; 16(1):390.

View in: PubMed
Klostranec JM, Chen L, Mathur S, McDonald J, Faughnan ME, Ratjen F, Krings T. A theory for polymicrogyria and brain arteriovenous malformations in HHT. Neurology. 2019 01 01; 92(1):34-42.

View in: PubMed
Meybodi AT, Kim H, Nelson J, Hetts SW, Krings T, terBrugge KG, Faughnan ME, Lawton MT. Surgical Treatment vs Nonsurgical Treatment for Brain Arteriovenous Malformations in Patients with Hereditary Hemorrhagic Telangiectasia: A Retrospective Multicenter Consortium Study. Neurosurgery. 2018 Jan 01; 82(1):35-47.

View in: PubMed
Kim H, Nelson J, Krings T, terBrugge KG, McCulloch CE, Lawton MT, Young WL, Faughnan ME. Hemorrhage rates from brain arteriovenous malformation in patients with hereditary hemorrhagic telangiectasia. Stroke. 2015 May; 46(5):1362-4.

View in: PubMed
Krings T, Kim H, Power S, Nelson J, Faughnan ME, Young WL, terBrugge KG. Neurovascular manifestations in hereditary hemorrhagic telangiectasia: imaging features and genotype-phenotype correlations. AJNR Am J Neuroradiol. 2015 May; 36(5):863-70.

View in: PubMed
Ting JY, Remenschneider A, Holbrook EH. Management of severe epistaxis after Young's procedure: a case report. Int Forum Allergy Rhinol. 2013 Apr; 3(4):334-7.

View in: PubMed

People

Explore

Similar Concepts

Top Journals